These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 17548493)

  • 21. Discovery of 4-acetyl-3-(4-fluorophenyl)-1-(p-tolyl)-5-methylpyrrole as a dual inhibitor of human P-glycoprotein and Staphylococcus aureus Nor A efflux pump.
    Bharate JB; Singh S; Wani A; Sharma S; Joshi P; Khan IA; Kumar A; Vishwakarma RA; Bharate SB
    Org Biomol Chem; 2015 May; 13(19):5424-31. PubMed ID: 25865846
    [TBL] [Abstract][Full Text] [Related]  

  • 22. P-glycoprotein efflux at the blood-brain barrier mediates differences in brain disposition and pharmacodynamics between two structurally related neurokinin-1 receptor antagonists.
    Smith BJ; Doran AC; McLean S; Tingley FD; O'Neill BT; Kajiji SM
    J Pharmacol Exp Ther; 2001 Sep; 298(3):1252-9. PubMed ID: 11504828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activity of quinupristin/dalfopristin against extracellular and intracellular Staphylococcus aureus with various resistance phenotypes.
    Baudoux P; Lemaire S; Denis O; Tulkens PM; Van Bambeke F; Glupczynski Y
    J Antimicrob Chemother; 2010 Jun; 65(6):1228-36. PubMed ID: 20378672
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conferone from Ferula schtschurowskiana enhances vinblastine cytotoxicity in MDCK-MDR1 cells by competitively inhibiting P-glycoprotein transport.
    Barthomeuf C; Demeule M; Grassi J; Saidkhodjaev A; Beliveau R
    Planta Med; 2006 Jun; 72(7):634-9. PubMed ID: 16739070
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhancement effect of P-gp inhibitors on the intestinal absorption and antiproliferative activity of bestatin.
    Huo X; Liu Q; Wang C; Meng Q; Sun H; Peng J; Ma X; Liu K
    Eur J Pharm Sci; 2013 Nov; 50(3-4):420-8. PubMed ID: 23981338
    [TBL] [Abstract][Full Text] [Related]  

  • 26. P-Glycoprotein expression in human retinal pigment epithelium cell lines.
    Constable PA; Lawrenson JG; Dolman DE; Arden GB; Abbott NJ
    Exp Eye Res; 2006 Jul; 83(1):24-30. PubMed ID: 16530756
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of P-glycoprotein transport function and reversion of MDR1 multidrug resistance by cnidiadin.
    Barthomeuf C; Grassi J; Demeule M; Fournier C; Boivin D; Béliveau R
    Cancer Chemother Pharmacol; 2005 Aug; 56(2):173-81. PubMed ID: 15824923
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Models to predict unbound intracellular drug concentrations in the presence of transporters.
    Korzekwa KR; Nagar S; Tucker J; Weiskircher EA; Bhoopathy S; Hidalgo IJ
    Drug Metab Dispos; 2012 May; 40(5):865-76. PubMed ID: 22279052
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amino acid prodrug of quinidine: an approach to circumvent P-glycoprotein mediated cellular efflux.
    Patel M; Mandava NK; Pal D; Mitra AK
    Int J Pharm; 2014 Apr; 464(1-2):196-204. PubMed ID: 24440401
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of P-glycoprotein-mediated renal drug interactions in an MDR1-MDCK model.
    Karyekar CS; Eddington ND; Garimella TS; Gubbins PO; Dowling TC
    Pharmacotherapy; 2003 Apr; 23(4):436-42. PubMed ID: 12680473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activity of simulated serum concentrations of daptomycin versus vancomycin during the first 24h of treatment in the presence of physiological albumin concentrations against vancomycin-susceptible, -tolerant or -intermediate-resistant Staphylococcus aureus.
    Torrico M; Aguilar L; Sevillano D; Giménez MJ; Alou L; González N; Cafini F; Cleeland R; Prieto J
    Int J Antimicrob Agents; 2011 Apr; 37(4):332-8. PubMed ID: 21388792
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Menadione serves as a substrate for P-glycoprotein: implication in chemosensitizing activity.
    Oh SJ; Han HK; Kang KW; Lee YJ; Lee MY
    Arch Pharm Res; 2013 Apr; 36(4):509-16. PubMed ID: 23435914
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retroviral transfection of Madin-Darby canine kidney cells with human MDR1 results in a major increase in globotriaosylceramide and 10(5)- to 10(6)-fold increased cell sensitivity to verocytotoxin. Role of p-glycoprotein in glycolipid synthesis.
    Lala P; Ito S; Lingwood CA
    J Biol Chem; 2000 Mar; 275(9):6246-51. PubMed ID: 10692420
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacodynamic evaluation of the intracellular activities of antibiotics against Staphylococcus aureus in a model of THP-1 macrophages.
    Barcia-Macay M; Seral C; Mingeot-Leclercq MP; Tulkens PM; Van Bambeke F
    Antimicrob Agents Chemother; 2006 Mar; 50(3):841-51. PubMed ID: 16495241
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overlapping substrate specificities of cytochrome P450 3A and P-glycoprotein for a novel cysteine protease inhibitor.
    Zhang Y; Guo X; Lin ET; Benet LZ
    Drug Metab Dispos; 1998 Apr; 26(4):360-6. PubMed ID: 9531525
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Establishment of optimized MDCK cell lines for reliable efflux transport studies.
    Gartzke D; Fricker G
    J Pharm Sci; 2014 Apr; 103(4):1298-304. PubMed ID: 24532159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro P-glycoprotein assays to predict the in vivo interactions of P-glycoprotein with drugs in the central nervous system.
    Feng B; Mills JB; Davidson RE; Mireles RJ; Janiszewski JS; Troutman MD; de Morais SM
    Drug Metab Dispos; 2008 Feb; 36(2):268-75. PubMed ID: 17962372
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of the modulation of the membrane lipid composition on the localization and function of P-glycoprotein in MDR1-MDCK cells.
    Kamau SW; Krämer SD; Günthert M; Wunderli-Allenspach H
    In Vitro Cell Dev Biol Anim; 2005; 41(7):207-16. PubMed ID: 16223335
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cellular accumulation of fluoroquinolones is not predictive of their intracellular activity: studies with gemifloxacin, moxifloxacin and ciprofloxacin in a pharmacokinetic/pharmacodynamic model of uninfected and infected macrophages.
    Vallet CM; Marquez B; Ngabirano E; Lemaire S; Mingeot-Leclercq MP; Tulkens PM; Van Bambeke F
    Int J Antimicrob Agents; 2011 Sep; 38(3):249-56. PubMed ID: 21764262
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Daptomycin pharmacodynamics against Staphylococcus aureus hemB mutants displaying the small colony variant phenotype.
    Begic D; von Eiff C; Tsuji BT
    J Antimicrob Chemother; 2009 May; 63(5):977-81. PubMed ID: 19304733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.